Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 4/2007

Open Access 01-04-2007 | Review

Successful Weight Loss Surgery Improves Eating Control and Energy Metabolism: A Review of the Evidence

Authors: Dave H. Schweitzer, MD, PhD, Emile F. Dubois, MD, PhD, Niki van den Doel-Tanis, BS, Hok I. Oei, MD

Published in: Obesity Surgery | Issue 4/2007

Login to get access

Abstract

Eating behavior is determined by a balance of memories in terms of reward and punishment to satisfy the urge to consume food. Refilling empty energy stores and hedonistic motivation are rewarding aspects of eating. Overfeeding, associated adverse GI effects, and obesity implicate punishment. In the current review, evidence is given for the hypothesis that bariatric surgery affects control over eating behavior.Moreover, any caloric overload will reduce the feeling of satiety. Durable weight loss after bariatric surgery is probably the result of a new equilibrium between reward and punishment, together with a better signaling of satiation due to beneficial metabolic changes.We propose to introduce three main treatment goals for bariatric surgery: 1) acceptable weight loss, 2) improvement of eating control, and 3) metabolic benefit. To achieve this goal, loss of 50% to 70% of excess weight will be appropriate (i.e. 30% to 40% loss of initial weight), depending on the degree of obesity prior to operation.
Literature
1.
World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: WHO, 1997; 894.
2.
3.
4.
Keesey RE, Hirvonen MD. Body weight set-points: determination and adjustment. J Nutr 1997; 127: 183S–875S.
5.
Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 2002; 106: 3143-21.
6.
Suter M, Calmes JM, Paroz A et al. A 10-year experience with laparoscopic gastric banding for morbid obesity: high long-term complication and failure rates. Obes Surg 2006; 16: 829-35.CrossRefPubMed
7.
Buchwald H, Avidor Y, Braunwald E et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-37.CrossRefPubMed
8.
Pavlov IP. The centrifugal (efferent) nerves to the gastric glands and of the pancreas. Thompson WH, translator. The Work of the Digestive Glands, 2nd Edn. Philadelphia: Charles Griffin, 1910: 48–59.
9.
Knutson U, Olbe L, Ganguli PC. Gastric acid and plasma gastrin responses to sham feeding in duodenal ulcer patients before and after resection of antrum and duodenal bulb. Scand J Gastroenterol 1974; 9: 351–.PubMed
10.
Richardson CT, Walsh JH, Cooper KA et al. Studies on the role of cephalic-vagal stimulation in the acid secretory response to eating in normal human subjects. J Clin Invest 1977; 60: 435–1.CrossRefPubMed
11.
Feldman M, Richardson CT. Role of thought, sight, smell, and taste of food in the cephalic phase of gastric acid secretion in humans. Gastroenterology 1986; 90: 428–3.PubMed
12.
Petrovich GD, Holland PC, Gallagher M. Amygdalar and prefrontal pathways to the lateral hypothalamus are activated by a learned cue that stimulates eating. J Neurosci 2005; 25: 8295–02.CrossRefPubMed
13.
Booth DA. Mood- and nutrient-conditioned appetites. Cultural and physiological bases for eating disorders. Ann N Y Acad Sci 1989; 575: 122–5 and discussion 157–2.CrossRefPubMed
14.
De Castro JM. Socio-cultural determinants of meal size and frequency. Br J Nutr 1997; Suppl 1: S39–S54.CrossRef
15.
Hoek J, Gendall P. Advertising and obesity: a behavioral perspective. J Health Commun 2006; 11: 409–3.CrossRefPubMed
16.
17.
Dallman MF, Akana SF, Strack AM et al. Chronic stressinduced effects of corticosterone on brain: direct and indirect. Ann NY Acad Sci 2004; 1018: 141–0.CrossRefPubMed
18.
Merali Z, McIntosh J, Anisman H. Anticipatory cues differentially provoke in vivo peptidergic and monoaminergic release at the medial prefrontal cortex. Neuropsychopharmacology 2004; 29: 1409–8.CrossRefPubMed
19.
Pecoraro N, Gomez F, Dallman MF. Glucocorticoids dosedependently remodel energy stores and amplify incentive relativity effects. Neuropsychopharmacology 2005; 30: 815–5.
20.
Erlanson-Albertsson C. How palatable food disrupts appetite regulation. Basic Clin Pharmacol Toxicol 2005; 97: 61–3.CrossRefPubMed
21.
Berridge KC. Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev 1996; 20: 1–5.CrossRefPubMed
22.
Epstein LH, Truesdale R, Wojcik A et al. Effects of deprivation on hedonistics and reinforcing value of food. Physiol Behav 2003; 78: 221–.CrossRefPubMed
23.
Kennedy GC. The regulation of food intake. Discussion. Adv Psychosom Med 1972; 7: 91–.PubMed
24.
25.
Niswender KD, Baskin DG, Schwartz MW. Insulin and its evolving partnership with leptin in the hypothalamic control of energy homeostasis. Trends Endocrinol Metab 2004; 15: 362–.PubMed
26.
Plum L, Schubert M, Bruning JC. The role of insulin receptor signaling in the brain. Trends Endocrinol Metab 2005; 16: 59–5.CrossRefPubMed
27.
Gerozissis K. Brain insulin and feeding: a bi-directional communication. Eur J Pharmacol 2004; 490: 59–0.CrossRefPubMed
28.
Obici S, Zhang BB, Karkanias G et al. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 2002; 8: 1376–2.CrossRefPubMed
29.
Pocai A, Lam TK, Gutierrez-Juarez R et al. Hypothalamic K (ATP) channels control hepatic glucose production. Nature 2005; 434: 1026–1.CrossRefPubMed
30.
Bruning JC, Gautam D, Burks DJ et al. Role of brain insulin receptor in control of body weight and reproduction. Science 2000; 289: 2122–.CrossRefPubMed
31.
Burks DJ, de Mora JF, Schubert M et al. IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 2000; 407: 377–2.CrossRefPubMed
32.
Halaas JL, Boozer C, Blair-West J et al. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci USA 1997; 94: 8878–3.CrossRef
33.
Schwartz MW, Woods SC, Porte D Jr et al. Central nervous system control of food intake. Nature 2000; 404: 661–1.PubMed
34.
Prodi E, Obici S. Minireview: the brain as a molecular target for diabetic therapy. Endocrinology 2006; 147: 2664–.CrossRefPubMed
35.
Baskin DG, Schwartz MW, Seeley RJ et al. Leptin receptor long-form splice-variant protein expression in neuron cell bodies of the brain and co-localization with neuropeptide Y mRNA in the arcuate nucleus. J Histochem Cytochem 1999; 47: 353–2.PubMed
36.
Niswender KD, Morrison CD, Clegg DJ et al. Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. Diabetes 2003; 52: 227–1.CrossRefPubMed
37.
Sun XJ, Rothenberg P, Kahn CR et al. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 1991; 352: 73–.CrossRefPubMed
38.
Sun XJ, Wang LM, Zhang Y et al. Role of IRS-2 in insulin and cytokine signaling. Nature 1995; 377: 173–.CrossRefPubMed
39.
Folli F, Saad MJ, Backer JM et al. Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat. J Biol Chem 1992; 267: 22171–.PubMed
40.
Carvalheira JB, Torsoni MA, Ueno M et al. Cross-talk between the insulin and leptin signaling systems in rat hypothalamus. Obes Res 2005; 13: 48–7.CrossRefPubMed
41.
Morton GJ, Gelling RW, Niswender KD et al. Leptin regulates insulin sensitivity via phosphatidylinositol-3-OH kinase signaling in mediobasal hypothalamic neurons. Cell Metab 2005; 2: 411–0.CrossRefPubMed
42.
Bjorbaek C, Uotani S, da Silva B et al. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem 1997; 272: 32686–5.CrossRefPubMed
43.
Bates SH, Meyers MG. The role of leptin→STAT3 signaling in neuroendocrine function: an integrative perspective. J Mol Med 2004; 82: 12–0.CrossRefPubMed
44.
Niswender KD, Morton GJ, Steams WH et al. Intracellular signaling. Key enzyme in leptin-induced anorexia. Nature 2001; 413: 794–.CrossRefPubMed
45.
Schwartz MW, Baskin DG, Bukowski TR et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996; 45: 531–5.CrossRefPubMed
46.
Schwartz MW, Seeley RJ, Woods SC et al. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 1997; 46: 2119–3.CrossRefPubMed
47.
Thornton JE, Cheung CC, Clifton DK et al. Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 1997; 138: 5063–6.CrossRefPubMed
48.
Mercer JG, Moar KM, Rayner DV et al. Regulation of leptin receptor and NPY gene expression in hypothalamus of leptin-treated obese (ob/ob) and cold-exposed lean mice. FEBS Lett 1997; 402: 185–.CrossRefPubMed
49.
Mizuno TM, Kleopoulos SP, Bergen HT et al. Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 1998; 47: 294–.CrossRefPubMed
50.
Cornier MA, Bergman BC, Bessesen DH. The effects of short-term overfeeding on insulin action in lean and reduced-obese individuals. Metabolism 2006; 55: 1207–4.CrossRefPubMed
51.
Tzatsos A, Kandror KV. Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTORmediated insulin receptor substrate 1 phosphorylation. Mol Cell Biol 2006; 26: 63–6.CrossRefPubMed
52.
Pocai A, Lam TK, Obici S et al. Restoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats. J Clin Invest 2006; 116: 1081–1.CrossRefPubMed
53.
54.
55.
Parfitt AM, Podenphant J, Villanueva AR et al. Metabolic bone disease with and without osteomalacia after intestinal bypass surgery: a bone histomorphometric study. Bone 1985; 6: 211–0.CrossRefPubMed
56.
The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. October 2000, NIH Pub No 00-4084.
57.
Rabner JG, Greenstein RJ. Obesity surgery: expectations and reality. Int J Obes Relat Metab Disord 1991; 15: 841–5.
58.
Foster GD, Wadden TA, Vogt RA et al. What is a reasonable weight loss? Patients–expectations and evaluations of obesity treatment outcomes. J Consult Clin Psychol 1997; 65: 79–5.CrossRefPubMed
59.
Sjostrom L, Lindroos AK, Peltonen M et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683–3.CrossRefPubMed
60.
Scopinaro N, Gianetta E, Civalleri D et al. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg 1979; 66: 618–0.CrossRefPubMed
61.
62.
Lagace M, Marceau P, Marceau S, et al. Biliopancreatic diversion with a new type of gastrectomy: some previous conclusions revisited. Obes Surg 1995; 5: 411–8.CrossRefPubMed
63.
Anthone GJ, Lord RV, DeMeester TR et al. The duodenal switch operation for the treatment of morbid obesity. Ann Surg 2003; 238: 618–7.PubMed
64.
Biron S, Hould FS, Lebel S et al. Twenty years of biliopancreatic diversion: what is the goal of the surgery? Obes Surg 2004; 14: 160–.CrossRefPubMed
65.
McConnell DB, O’rourke RW, Deveney CW. Common channel length predicts outcomes of biliopancreatic diversion alone and with the duodenal switch surgery. Am J Surg 2005; 189: 536–0.CrossRefPubMed
66.
Dalle Grave R, Calugi S, Magri F et al. Weight loss expectations in obese patients seeking treatment at medical centers. Obes Res 2004; 12: 2005–2.CrossRefPubMed
Metadata
Title
Successful Weight Loss Surgery Improves Eating Control and Energy Metabolism: A Review of the Evidence
Authors
Dave H. Schweitzer, MD, PhD
Emile F. Dubois, MD, PhD
Niki van den Doel-Tanis, BS
Hok I. Oei, MD
Publication date
01-04-2007
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 4/2007
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-007-9092-4

Other articles of this Issue 4/2007

Obesity Surgery 4/2007 Go to the issue

OriginalPaper

Intragastric Balloon and Binge Eating

Case Report

Hypovolemic Shock due to Intragastric Migration of an Adjustable Gastric Band

OriginalPaper

IL-6 and IGF-1 are Independent Prognostic Factors of Liver Steatosis and Non-Alcoholic Steatohepatitis in Morbidly Obese Patients

OriginalPaper

Eating Behavior as a Prognostic Factor for Weight Loss after Gastric Bypass

OriginalPaper

Sexual Abuse Survivors and Psychiatric Hospitalization after Bariatric Surgery

OriginalPaper

Associations of Weight-Based Teasing History and Current Eating Disorder Features and Psychological Functioning in Bariatric Surgery Patients